SOPHiA GENETICS (SOPH)
NASDAQ:SOPH
US Market
Holding SOPH?
Track your performance easily

SOPHiA GENETICS (SOPH) Financial Statements

72 Followers

SOPHiA GENETICS Financial Overview

SOPHiA GENETICS's market cap is currently ―. The company's EPS TTM is $-1.021; its P/E ratio is -3.52; SOPHiA GENETICS is scheduled to report earnings on November 5, 2024, and the estimated EPS forecast is $-0.22. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue--$ 11.65M$ 11.67M$ 10.86M
Gross Profit--$ 7.29M$ 7.62M$ 6.71M
EBIT--$ -23.64M$ -24.08M$ -25.02M
EBITDA--$ -22.19M$ -22.69M$ -23.83M
Net Income Common Stockholders--$ -23.31M$ -24.68M$ -25.49M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 121.12M$ 178.61M$ 189.25M$ 216.61M$ 243.52M
Total Assets$ 206.16M$ 243.84M$ 250.59M$ 277.22M$ 297.55M
Total Debt$ 2.93M$ 16.74M$ 16.25M$ 16.76M$ 12.54M
Net Debt$ -118.19M$ -161.86M$ -173.00M$ -199.85M$ -230.98M
Total Liabilities$ 54.71M$ 43.71M$ 44.70M$ 49.11M$ 45.64M
Stockholders Equity$ 151.44M$ 172.70M$ 205.89M$ 228.12M$ 251.91M
Cash Flow-
Free Cash Flow--$ -24.98M$ -22.49M$ -19.51M
Operating Cash Flow--$ -22.82M$ -19.55M$ -17.40M
Investing Cash Flow--$ 3.13M$ 17.99M$ 8.71M
Financing Cash Flow--$ -809.00K$ 232.00K$ -411.00K
Currency in USD

SOPHiA GENETICS Earnings and Revenue History

SOPHiA GENETICS Debt to Assets

SOPHiA GENETICS Cash Flow

SOPHiA GENETICS Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis